Trial Profile
Efficacy of Moxifloxacin in patients with Ofloxacin-resistant multidrug resistant tuberculosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Oct 2016
Price :
$35
*
At a glance
- Drugs Moxifloxacin (Primary)
- Indications Tuberculosis
- Focus Therapeutic Use
- 14 Oct 2016 New trial record